TWEAK and the kidney: The dual role of a multifunctional cytokine

Advances in Experimental Medicine and Biology

Volumn 691, Issue , 2011, Pages 323-335

  Ortiz, Ana ^a   Sanchez Nino M D ^a   Izquierdo, M C ^a   Blanco Colio, L M ^a   Selgas, R ^b   Ruiz Ortega, M ^a   Egido, J ^a   Sanz, Ana B ^c  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b Section of Nephrology   (Spain)

^c HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR INDUCIBLE MOLECULE 14; GAMMA INTERFERON; MEMBRANE PROTEIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR LIKE WEAK INDUCER OF APOPTOSIS; UNCLASSIFIED DRUG; CYTOKINE; TNFSF12 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR RECEPTOR; TWEAK RECEPTOR;

ACUTE KIDNEY FAILURE; CELL DEATH; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CHRONIC KIDNEY DISEASE; CONFERENCE PAPER; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DIALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; EPITHELIAL MESENCHYMAL TRANSITION; FIBROBLAST; HUMAN; HYPERPLASIA; INFLAMMATION; KIDNEY FAILURE; KIDNEY FIBROSIS; KIDNEY HYPERPLASIA; KIDNEY HYPERTROPHY; KIDNEY TUBULE DISORDER; KIDNEY TUBULE EPITHELIUM; LUPUS ERYTHEMATOSUS NEPHRITIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; UNINEPHRECTOMY; ANIMAL; DISEASE MODEL; KIDNEY; KIDNEY DISEASE; METABOLISM; PATHOLOGY; REVIEW;

ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; HUMANS; KIDNEY; KIDNEY DISEASES; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTORS;

EID: 79954446838     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-6612-4_33     Document Type: Conference Paper

References (61)

1. Alderson MR, Armitage RJ, Maraskovsky E, Tough TW, Roux E, Schooley K, Ramsdell F, Lynch DH (1993) Fas transduces activation signals in normal human T lymphocytes. J Exp Med 178:2231-2235
2. Ando T, Ichikawa J, Wako M, Hatsushika K, Watanabe Y, Sakuma M, Tasaka K, Ogawa H, Hamada Y, Yagita H, Nakao A (2006) TWEAK/Fn14 interaction regulates RANTES production, BMP-2-induced differentiation, and RANKL expression in mouse osteoblastic MC3T3-E1 cells. Arthritis Res Ther 8:R146
3. Burkly LC, Michaelson JS, Hahm K, Jakubowski A, Zheng TS (2007) TWEAKing tissue remodeling by a multifunctional cytokine: Role of TWEAK/Fn14 pathway in health and disease. Cytokine 40:1-16
4. Campbell S, Burkly LC, Gao HX, Berman JW, Su L, Browning B, Zheng T, Schiffer L, Michaelson JS, Putterman C (2006) Proinflammatory effects of TWEAK/Fn14 interactions in glomerular mesangial cells. J Immunol 176:1889-1898
5. Chicheportiche Y, Bourdon PR, Xu H, Hsu YM, Scott H, Hession C, Garcia I, Browning JL (1997) TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis. J Biol Chem 272:32401-32410
6. de Haij S, Woltman AM, Bakker AC, Daha MR, van KC (2002) Production of inflammatory mediators by renal epithelial cells is insensitive to glucocorticoids. Br J Pharmacol 137: 197-204
7. Desplat-Jego S, Creidy R, Varriale S, Allaire N, Luo Y, Bernard D, Hahm K, Burkly L, Boucraut J (2005) Anti-TWEAK monoclonal antibodies reduce immune cell infiltration in the central nervous system and severity of experimental autoimmune encephalomyelitis. Clin Immunol 117:15-23
8. Desplat-Jego S, Varriale S, Creidy R, Terra R, Bernard D, Khrestchatisky M, Izui S, Chicheportiche Y, Boucraut J (2002) TWEAK is expressed by glial cells, induces astrocyte proliferation and increases EAE severity. J Neuroimmunol 133:116-123
9. Donohue PJ, Richards CM, Brown SA, Hanscom HN, Buschman J, Thangada S, Hla T, Williams MS, Winkles JA (2003) TWEAK is an endothelial cell growth and chemotactic factor that also potentiates FGF-2 and VEGF-A mitogenic activity. Arterioscler Thromb Vasc Biol 23:594-600
10. Feng SL, Guo Y, Factor VM, Thorgeirsson SS, Bell DW, Testa JR, Peifley KA, Winkles JA (2000) The Fn14 immediate-early response gene is induced during liver regeneration and highly expressed in both human and murine hepatocellular carcinomas. Am J Pathol 156:1253-1261
11. Flyvbjerg A, Bennett WF, Rasch R, van Neck JW, Groffen CA, Kopchick JJ, Scarlett JA (1999) Compensatory renal growth in uninephrectomized adult mice is growth hormone dependent. Kidney Int 56:2048-2054
12. Gao HX, Campbell SR, Burkly LC, Jakubowski A, Jarchum I, Banas B, Saleem MA, Mathieson PW, Berman JW, Michaelson JS, Putterman C (2009) TNF-like weak inducer of apoptosis (TWEAK) induces inflammatory and proliferative effects in human kidney cells. Cytokine 46:24-35
13. Girgenrath M, Weng S, Kostek CA, Browning B, Wang M, Brown SA, Winkles JA, Michaelson JS, Allaire N, Schneider P, Scott ML, Hsu YM, Yagita H, Flavell RA, Miller JB, Burkly LC, Zheng TS (2006) TWEAK, via its receptor Fn14, is a novel regulator of mesenchymal progenitor cells and skeletal muscle regeneration. EMBO J 25: 5826-5839
14. Goes N, Urmson J, Vincent D, Halloran PF (1995) Acute renal injury in the interferon-gamma gene knockout mouse: Effect on cytokine gene expression. Transplantation 60:1560-1564
15. Higashitsuji H, Arii S, Furutani M, Mise M, Monden K, Fujita S, Ishiguro S, Kitao T, Nakamura T, Nakayama H (1995) Expression of cytokine genes during liver regeneration after partial hepatectomy in rats. J Surg Res 58:267-274
16. Jakubowski A, Ambrose C, Parr M, Lincecum JM, Wang MZ, Zheng TS, Browning B, Michaelson JS, Baetscher M, Wang B, Bissell DM, Burkly LC (2005) TWEAK induces liver progenitor cell proliferation. J Clin Invest 115:2330-2340
17. Justo P, Sanz A, Lorz C, Gomez-Garre D, Mezzano S, Egido J, Ortiz A (2003) Expression of Smac/Diablo in tubular epithelial cells and during acute renal failure. Kidney Int Suppl. S52-S56
18. Justo P, Sanz AB, Sanchez-Nino MD, Winkles JA, Lorz C, Egido J, Ortiz A (2006) Cytokine cooperation in renal tubular cell injury: The role of TWEAK. Kidney Int 70: 1750-1758
19. Kamata K, Kamijo S, Nakajima A, Koyanagi A, Kurosawa H, Yagita H, Okumura K (2006) Involvement of TNF-like weak inducer of apoptosis in the pathogenesis of collagen-induced arthritis. J Immunol 177:6433-6439
20. Kaplan MJ, Lewis EE, Shelden EA, Somers E, Pavlic R, McCune WJ, Richardson BC (2002) The apoptotic ligands TRAIL, TWEAK, and Fas ligand mediate monocyte death induced by autologous lupus T cells. J Immunol 169:6020-6029
21. Kim SH, Kang YJ, Kim WJ, Woo DK, Lee Y, Kim DI, Park YB, Kwon BS, Park JE, Lee WH (2004) TWEAK can induce pro-inflammatory cytokines and matrix metalloproteinase-9 in macrophages. Circ J 68:396-399
22. Locksley RM, Killeen N, Lenardo MJ (2001) The TNF and TNF receptor superfamilies: Integrating mammalian biology. Cell 104:487-501
23. Lorz C, Benito-Martin A, Boucherot A, Ucero AC, Rastaldi MP, Henger A, Armelloni S, Santamaria B, Berthier CC, Kretzler M, Egido J, Ortiz A (2008) The death ligand TRAIL in diabetic nephropathy. J Am Soc Nephrol 19:904-914
24. Lynch CN, Wang YC, Lund JK, Chen YW, Leal JA, Wiley SR (1999) TWEAK induces angiogenesis and proliferation of endothelial cells. J Biol Chem 274:8455-8459
25. Maecker H, Varfolomeev E, Kischkel F, Lawrence D, LeBlanc H, Lee W, Hurst S, Danilenko D, Li J, Filvaroff E, Yang B, Daniel D, Ashkenazi A (2005) TWEAK attenuates the transition from innate to adaptive immunity. Cell 123:931-944
26. Marsters SA, Sheridan JP, Pitti RM, Brush J, Goddard A, Ashkenazi A (1998) Identification of a ligand for the death-domain-containing receptor Apo3. Curr Biol 8:525-528
27. Meighan-Mantha RL, Hsu DK, Guo Y, Brown SA, Feng SL, Peifley KA, Alberts GF, Copeland NG, Gilbert DJ, Jenkins NA, Richards CM, Winkles JA (1999) The mitogeninducible Fn14 gene encodes a type I transmembrane protein that modulates fibroblast adhesion and migration. J Biol Chem 274:33166-33176
28. Metz-Kurschel U, Kurschel E, Wagner K, Aulbert E, Graben N, Philipp T (1990) Folate nephropathy occurring during cytotoxic chemotherapy with high-dose folinic acid and 5-fluorouracil. Ren Fail 12:93-97
29. Mitsiades CS, Poulaki V, Fanourakis G, Sozopoulos E, McMillin D, Wen Z, Voutsinas G, Tseleni-Balafouta S, Mitsiades N (2006) Fas signaling in thyroid carcinomas is diverted from apoptosis to proliferation. Clin Cancer Res 12:3705-3712
30. Molano A, Lakhani P, Aran A, Burkly LC, Michaelson JS, Putterman C (2009) TWEAK stimulation of kidney resident cells in the pathogenesis of graft versus host induced lupus nephritis. Immunol Lett 125:119-128
31. Mueller AM, Pedre X, Kleiter I, Hornberg M, Steinbrecher A, Giegerich G (2005) Targeting fibroblast growth factor-inducible-14 signaling protects from chronic relapsing experimental autoimmune encephalomyelitis. J Neuroimmunol 159:55-65
32. Nakayama M, Harada N, Okumura K, Yagita H (2003a) Characterization of murine TWEAK and its receptor (Fn14) by monoclonal antibodies. Biochem Biophys Res Commun 306: 819-825
33. Nakayama M, Ishidoh K, Kayagaki N, Kojima Y, Yamaguchi N, Nakano H, Kominami E, Okumura K, Yagita H (2002) Multiple pathways of TWEAK-induced cell death. J Immunol 168:734-743
34. Nakayama M, Ishidoh K, Kojima Y, Harada N, Kominami E, Okumura K, Yagita H (2003b) Fibroblast growth factor-inducible 14 mediates multiple pathways of TWEAK-induced cell death. J Immunol 170:341-348
35. Nakayama M, Kayagaki N, Yamaguchi N, Okumura K, Yagita H (2000) Involvement of TWEAK in interferon gamma-stimulated monocyte cytotoxicity. J Exp Med 192:1373-1380
36. NaumannM, Nieters A, Hatada EN, Scheidereit C (1993) NF-kappa B precursor p100 inhibits nuclear translocation and DNA binding of NF-kappa B/rel-factors. Oncogene 8:2275-2281
37. Olsen TS, Hansen HE, Olsen HS (1985) Tubular ultrastructure in acute renal failure: Alterations of cellular surfaces (brush-border and basolateral infoldings). Virchows Arch A Pathol Anat Histopathol 406:91-104
38. Ortega A, Ramila D, Ardura JA, Esteban V, Ruiz-Ortega M, Barat A, Gazapo R, Bosch RJ, Esbrit P (2006) Role of parathyroid hormone-related protein in tubulointerstitial apoptosis and fibrosis after folic acid-induced nephrotoxicity. J Am Soc Nephrol 17:1594-1603
39. Ortiz A, Bustos C, Alonso J, Alcazar R, Lopez-Armada MJ, Plaza JJ, Gonzalez E, Egido J (1995) Involvement of tumor necrosis factor-alpha in the pathogenesis of experimental and human glomerulonephritis. Adv Nephrol Necker Hosp 24:53-77
40. Ortiz A, Justo P, Catalan MP, Sanz AB, Lorz C, Egido J (2002) Apoptotic cell death in renal injury: The rationale for intervention. Curr Drug Targets Immune Endocr Metabol Disord 2:181-192
41. Ortiz A, Justo P, Sanz A, Lorz C, Egido J (2003) Targeting apoptosis in acute tubular injury. Biochem Pharmacol 66:1589-1594
42. Ortiz A, Lorz C, Catalan MP, Danoff TM, Yamasaki Y, Egido J, Neilson EG (2000) Expression of apoptosis regulatory proteins in tubular epithelium stressed in culture or following acute renal failure. Kidney Int 57:969-981
43. Ortiz A, Lorz C, Egido J (1999) New kids in the block: The role of FasL and Fas in kidney damage. J Nephrol 12:150-158
44. Ortiz A, Lorz C, Gonzalez-Cuadrado S, Garcia del MR, O'Valle F, Egido J (1997) Cytokines and Fas regulate apoptosis in murine renal interstitial fibroblasts. J Am Soc Nephrol 8: 1845-1854
45. Potrovita I, Zhang W, Burkly L, Hahm K, Lincecum J, Wang MZ, Maurer MH, Rossner M, Schneider A, Schwaninger M (2004) Tumor necrosis factor-like weak inducer of apoptosisinduced neurodegeneration. J Neurosci 24:8237-8244
46. Saitoh T, Nakayama M, Nakano H, Yagita H, Yamamoto N, Yamaoka S (2003) TWEAK induces NF-kappaB2 p100 processing and long lasting NF-kappaB activation. J Biol Chem 278:36005-36012
47. Sanz AB, Justo P, Sanchez-Nino MD, Blanco-Colio LM,Winkles JA, KreztlerM, Jakubowski A, Blanco J, Egido J, Ruiz-Ortega M, Ortiz A (2008a) The cytokine TWEAK modulates renal tubulointerstitial inflammation. J Am Soc Nephrol 19:695-703
48. Sanz AB, Sanchez-Nino MD, Izquierdo MC, Jakubowski A, Justo P, Blanco-Colio LM, Ruiz- Ortega M, Egido J, Ortiz A (2009) TWEAK induces proliferation in renal tubular epithelium: A role in uninephrectomy-induced renal hyperplasia. J Cell Mol Med. 2009 May 1. [Epub ahead of print]
49. Sanz AB, Santamaria B, Ruiz-Ortega M, Egido J, Ortiz A (2008b) Mechanisms of renal apoptosis in health and disease. J Am Soc Nephrol 19:1634-1642
50. Schwartz N, Su L, Burkly LC, Mackay M, Aranow C, Kollaros M, Michaelson JS, Rovin B, Putterman C (2006) Urinary TWEAK and the activity of lupus nephritis. J Autoimmun 27:242-250
51. Solez K, Morel-Maroger L, Sraer JD (1979) The morphology of "acute tubular necrosis" in man: Analysis of 57 renal biopsies and a comparison with the glycerol model. Medicine (Baltimore) 58:362-376
52. Sun J, Langer WJ, Devish K, Lane PH (2006) Compensatory kidney growth in estrogen receptor-alpha null mice. Am J Physiol Renal Physiol 290:F319-F323
53. Tanabe K, Bonilla I, Winkles JA, Strittmatter SM (2003) Fibroblast growth factor-inducible- 14 is induced in axotomized neurons and promotes neurite outgrowth. J Neurosci 23: 9675-9686
54. Thurman JM (2007) Triggers of inflammation after renal ischemia/reperfusion. Clin Immunol 123:7-13
55. Tran NL, McDonough WS, Savitch BA, Sawyer TF, Winkles JA, Berens ME (2005) The tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-fibroblast growth factorinducible 14 (Fn14) signaling system regulates glioma cell survival via NFkappaB pathway activation and BCL-XL/BCL-W expression. J Biol Chem 280:3483-3492
56. van KC, Daha MR, van Es LA (1999) Tubular epithelial cells: A critical cell type in the regulation of renal inflammatory processes. Exp Nephrol 7:429-437
57. Vince JE, Chau D, Callus B, Wong WW, Hawkins CJ, Schneider P, McKinlay M, Benetatos CA, Condon SM, Chunduru SK, Yeoh G, Brink R, Vaux DL, Silke J (2008) TWEAK-FN14 signaling induces lysosomal degradation of a cIAP1-TRAF2 complex to sensitize tumor cells to TNFalpha. J Cell Biol 182:171-184
58. Webber EM, Bruix J, Pierce RH, Fausto N (1998) Tumor necrosis factor primes hepatocytes for DNA replication in the rat. Hepatology 28:1226-1234
59. Winkles JA (2008) The TWEAK-Fn14 cytokine-receptor axis: Discovery, biology and therapeutic targeting. Nat Rev Drug Discov 7:411-425
60. Yamada Y, Webber EM, Kirillova I, Peschon JJ, Fausto N (1998) Analysis of liver regeneration in mice lacking type 1 or type 2 tumor necrosis factor receptor: Requirement for type 1 but not type 2 receptor. Hepatology 28:959-970
61. Zhao Z, Burkly LC, Campbell S, Schwartz N, Molano A, Choudhury A, Eisenberg RA, Michaelson JS, Putterman C (2007) TWEAK/Fn14 interactions are instrumental in the pathogenesis of nephritis in the chronic graft-versus-host model of systemic lupus erythematosus. J Immunol 179:7949-7958